The Russian Direct Investment Fund : Sputnik V demonstrates 94.3% efficacy and high safety profile during the vaccination campaign in Bahrain – MENAFN.COM

SourceMENAFN
SectorEconomy
CountryBahrain

Moscow: The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the data of the Ministry of Health of the Kingdom of Bahrain on the Russian Sputnik V coronavirus vaccine confirming its safety and high efficacy during the vaccination campaign in the country. An efficacy study was conducted in Bahrain in accordance with WHO guidelines involving more than 5, 000 subjects. Overall efficacy beyond 14 days after administering the second dose was estimated at 94.

3%. Analysis is based on the data collected between February and early May 2021. The data of the Ministry of Health also demonstrates that 98. 6% of all COVID-19 cases 14 days after receiving the second dose were mild among those vaccinated with Sputnik V. Vaccination data indicates high safety of Sputnik V: Kirill Dmitriev, CEO of the Russian Direct Investment Fund (RDIF), said: “Sputnik V has demonstrated efficacy of 94. 3% and high safety confirming the data collected in a number of...read more...